Rosella Cicconi Selected Research

5,7-dimethoxycoumarin

6/2009	Inhibition of Mek 1/2 kinase activity and stimulation of melanogenesis by 5,7-dimethoxycoumarin treatment of melanoma cells.
2/2008	Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosella Cicconi Research Topics

Disease

9	Neoplasms (Cancer) 06/2020 - 02/2008
6	Melanoma (Melanoma, Malignant) 01/2020 - 02/2008
1	Infertility (Sterility) 10/2021
1	Weight Loss (Weight Reduction) 10/2021
1	Colitis 02/2021
1	Carcinogenesis 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Infections 01/2019
1	Inflammation (Inflammations) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Obesity 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Atherosclerosis 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2016
1	Disease Progression 11/2016
1	Malignant Mesothelioma 02/2013
1	Mesothelioma 02/2013
1	Communicable Diseases (Infectious Diseases) 06/2010
1	Tuberculosis (Tuberculoses) 05/2010

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020 - 11/2016
3	Trypan Blue FDA Link 01/2015 - 02/2008
3	Phosphotransferases (Kinase)IBA 02/2011 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 06/2020 - 06/2009
2	EnzymesIBA 02/2013 - 06/2009
2	protoporphyrin IXIBA 02/2011 - 02/2008
2	chrysinIBA 02/2011 - 10/2010
2	5,7-dimethoxycoumarinIBA 06/2009 - 02/2008
1	Dextran SulfateIBA 02/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 06/2020
1	Pharmaceutical PreparationsIBA 06/2020
1	Monoclonal AntibodiesIBA 01/2020
1	D16F7IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Placenta Growth FactorIBA 01/2020
1	Vascular Endothelial Growth Factor BIBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2020
1	Histones (Histone)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Oxidized LDL ReceptorsIBA 01/2019
1	CateninsIBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2016
1	Ellagic AcidIBA 11/2016
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2016
1	Cytotoxins (Cytolysins)IBA 01/2015
1	Complex MixturesIBA 01/2015
1	PlatinumIBA 02/2013
1	Glutathione (Reduced Glutathione)IBA 02/2013
1	Cisplatin (Platino)FDA LinkGeneric 02/2013
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2013
1	Biological ProductsIBA 02/2011
1	CaspasesIBA 02/2011
1	AntioxidantsIBA 10/2010
1	thiazolyl blueIBA 10/2010
1	VaccinesIBA 06/2010
1	AntigensIBA 05/2010
1	U 0126 (UO 126)IBA 06/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2009
1	Monophenol Monooxygenase (Tyrosinase)IBA 06/2009
1	Mitogen-Activated Protein KinasesIBA 02/2008
1	Cytostatic AgentsIBA 02/2008
1	Melanins (Melanin)IBA 02/2008

Therapy/Procedure

5	Therapeutics 06/2020 - 10/2010
1	Transplantation 10/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Oral Administration 02/2021
1	Precision Medicine 06/2020
1	Immunotherapy 01/2020
1	Intravenous Injections 01/2019
1	Heterologous Transplantation (Xenotransplantation) 01/2019